Market Tracker

10/24 6:05pm ET

Novo Nordisk A/S (NYSE:NVO)

45.77
Data as of Oct 24
 +0.05 / +0.11%
Today’s Change
33.04
Today|||52-Week Range
49.11
+23.86%
Year-to-Date

Today’s Trading

Previous close45.72
Today’s open45.66
Day’s range44.91 - 45.84
Volume3,939,307
Average volume (3 months)1,159,124
Market cap$95.1B
Dividend yield1.81%
Data as of 4:02pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+23.61%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.90%
Revenue growth (last year)+10.11%
P/E ratio--
Price/Sales6.64
Price/Book15.41

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie Inc+0.77+1.29%
BMYBristol-Myers Squibb...+1.13+2.15%
AZNAstraZeneca PLC+0.77+1.11%
CELGCelgene Corp+2.84+2.83%
Data as of 4:02pm ET, 10/24/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)$0.43
Annual revenue (last year)$14.9B
Annual profit (last year)$4.5B
Net profit margin30.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts